Broadening Access to COVID-19 Drugs
Regulators should expand the types of medical professionals who can prescribe COVID-19 drugs.
Negotiating Prices with Drug Manufacturers
The Inflation Reduction Act aims to constrain rapidly increasing drug prices in the United States.
Regulating Drugs at a Discount
Scholars examine the effectiveness of the contentious 340B Drug Pricing Program.
How America Turns Competitors Into Colleagues
The collaboration between pharmaceutical giants puts antitrust law at risk.
Regulating Prescription Drug Costs
Experts consider how regulators can make drugs affordable without hindering research and development.
Is the 21st Century Cures Act a Solution or a Problem?
The permissive drug approval process enabled by the 21st Century Cures Act may cause public health problems.